Inovio Pharmaceuticals, Inc.
INO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001055726
No open-market purchases or sales by Inovio Pharmaceuticals, Inc. insiders were filed in the last 90 days; 101 institutions reported holding it in 13F filings for Q2 2026, worth $36.1M in total; no superinvestor holds it.
Q3 2024 vs. Q2 2024
How the institutions holding Inovio Pharmaceuticals, Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 96 | 3 | 98 | +5 |
| Shares | 8.06M | 1.81M | 8.57M | +2.32M (+37.0%) |
| Value | $65.1M | $14.6M | $49.5M | −$998.1K (−2.0%) |
3 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (21)
Institutions that held Inovio Pharmaceuticals, Inc. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BlackRock, Inc. | 1,885,595 | $10.9M | 0.00% |
| GMT Capital Corp | 126,121 | $729.0K | 0.03% |
| Deerfield Management Company, L.P. (Series C) | 76,523 | $442.3K | 0.01% |
| Wellington Management Group LLP | 65,633 | $379.4K | 0.00% |
| Squarepoint Ops LLC | 51,528 | $297.8K | 0.00% |
| Susquehanna International Group, LLP | 30,071 | $173.8K | 0.00% |
| Atom Investors LP | 17,747 | $102.6K | 0.01% |
| Deutsche Bank AG | 14,387 | $83.2K | 0.00% |
| Mirae Asset Global ETFs Holdings Ltd. | 13,950 | $80.6K | 0.00% |
| SG Americas Securities, LLC | 12,286 | $71.0K | 0.00% |
| Pathstone Holdings, LLC | 10,266 | $59.3K | 0.00% |
| nVerses Capital, LLC | 1,000 | $5.78K | 0.00% |
| Capital Performance Advisors LLP | 83 | $480 | 0.00% |
| Sterling Capital Management LLC | 81 | $468 | 0.00% |
| GWM Advisors LLC | 58 | $335 | 0.00% |
| Nisa Investment Advisors, LLC | 33 | $191 | 0.00% |
| GAMMA Investing LLC | 24 | $139 | 0.00% |
| Tortoise Investment Management, LLC | 20 | $116 | 0.00% |
| Northwestern Mutual Wealth Management Co | 2 | $12 | 0.00% |
| Hemington Wealth Management | 97 | $0 | 0.00% |
| Householder Group Estate & Retirement Specialist, LLC | 106 | $0 | 0.00% |
Sold out (16)
Institutions that held Inovio Pharmaceuticals, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Alpine Global Management, LLC | 24,916 | $201.3K |
| Cornercap Investment Counsel Inc | 22,712 | $183.5K |
| Jump Financial, LLC | 21,756 | $175.8K |
| Corton Capital Inc. | 20,283 | $163.9K |
| Walleye Capital LLC | 18,758 | $151.6K |
| Jacobs Levy Equity Management, Inc | 16,497 | $133.3K |
| Graham Capital Management, L.P. | 12,712 | $102.7K |
| Manufacturers Life Insurance Company, The | 10,169 | $82.2K |
| Prime Capital Investment Advisors, LLC | 10,036 | $81.1K |
| CIBC Private Wealth Group, LLC | 358 | $3.11K |
| Macquarie Group Ltd | 125 | $1.01K |
| International Assets Investment Management, LLC | 94 | $760 |
| Huntington National Bank | 16 | $129 |
| ORG Partners LLC | 8 | $68 |
| Financial Network Wealth Advisors LLC | 8 | $65 |
| CBIZ Investment Advisory Services, LLC | 4 | $32 |
Not filed for Q3 2024 yet (3)
Institutions that held Inovio Pharmaceuticals, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 1,706,420 | $13.8M |
| Susquehanna Fundamental Investments, LLC | 99,991 | $807.9K |
| ICA Group Wealth Management, LLC | 79 | $638 |